Tech Company Financing Transactions

AtheroMed Funding Round

On 5/6/2011, AtheroMed received $7.5 million in funding from Canaan Partners, Kaiser Permanente Ventures and U.S. Venture Partners.

Transaction Overview

Company Name
Announced On
5/6/2011
Transaction Type
Venture Equity
Amount
$7,527,761
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.

Company Information

Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
1455 Adams Dr. 1120
Menlo Park, CA 94025
USA
Email Address
Overview
The company is developing treatments for Peripheral Arterial Disease (PAD).
Profile
AtheroMed LinkedIn Company Profile
Social Media
AtheroMed Company Twitter Account
Company News
AtheroMed News
Facebook
AtheroMed on Facebook
YouTube
AtheroMed on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Chris Danek
  Chris Danek LinkedIn Profile  Chris Danek Twitter Account  Chris Danek News  Chris Danek on Facebook


 

 

Browse more venture capital transactions:

Prev: 5/6/2011: ImagineOptix venture capital transaction
Next: 5/6/2011: Quirky venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document all VC transactions involving tech companies. VC investment data records reported here are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary